Episode
MMF Rewind | Inside the World's Busiest Kidney Transplant Center
- Podcast
- Moving Medicine Forward
- Published
- Mar 12, 2026
- Duration seconds
- 2301
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/moving-medicine-forward-6832193/episodes/mmf-rewind-inside-the-world-s-busiest-kidney-transplant-center/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/moving-medicine-forward-6832193/mmf-rewind-inside-the-world-s-busiest-kidney-transplant-center.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In honor of World Kidney Day , we’re rereleasing this timely and insightful episode of Moving Medicine Forward . In this conversation, we sit down with Dr. Helio Tedesco , a globally recognized transplant nephrologist from São Paulo, Brazil, who leads one of the world’s largest kidney transplant programs and is now part of the CTI team . Joined by Dr. Christopher Boshkos , Senior Medical Director at CTI, and clinical scientist Erika Aldag , the discussion explores the challenges and innovations behind managing more than 15,000 transplant patients—from telehealth expansion and donor matching to cutting-edge immunosuppressive strategies and the future of surveillance tools such as cell-free DNA and the iBox model. This episode offers a rare look into the science, systems, and human dedication driving transplant care forward. 00:35 Dr. Helio Tedesco (São Paulo), Dr. Christopher Boshkos, and Clinical Scientist Erika Aldag join to discuss global kidney transplant practices. 01:13 Dr. Tedesco shares his background, highlighting nearly 40 years in nephrology, performing over 1,000 kidney transplants annually, and a strong foundation in research. 03:17 Managing large transplant populations involves strategic follow-up care, decentralized nephrology networks, and an expanding role for telehealth. 06:30 How patients are matched to regimens, minimizing rejection and addressing regional challenges. 11:49 Dr. Tedesco explains their one-dose thymoglobulin approach and its benefits over traditional multi-dose methods. 18:34 New tools for monitoring graft health include donor-derived cell-free DNA, advanced biopsy techniques, and an examination of barriers to widespread adoption. 24:25 Discussion on the potential of the iBox model as a predictive tool for clinical trials and long-term…